nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.0901	0.107	CcSEcCtD
Sodium lauryl sulfate—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.068	0.435	CbGpPWpGaD
Sodium lauryl sulfate—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.0664	0.0787	CcSEcCtD
Sodium lauryl sulfate—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0445	0.0527	CcSEcCtD
Sodium lauryl sulfate—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.033	0.0391	CcSEcCtD
Sodium lauryl sulfate—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0287	0.0341	CcSEcCtD
Sodium lauryl sulfate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0271	0.173	CbGpPWpGaD
Sodium lauryl sulfate—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0266	0.0316	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0237	0.0282	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0231	0.0274	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0221	0.0261	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0219	0.026	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0193	0.0228	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0228	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0227	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0175	0.0207	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0186	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.015	0.0178	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.015	0.0177	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0171	CcSEcCtD
Sodium lauryl sulfate—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0162	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0135	0.016	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0159	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.013	0.0154	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.013	0.0154	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0148	CcSEcCtD
Sodium lauryl sulfate—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0148	CcSEcCtD
Sodium lauryl sulfate—Shock—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0145	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0144	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.012	0.0143	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0141	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0138	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0133	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0132	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0128	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0127	CcSEcCtD
Sodium lauryl sulfate—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0126	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0121	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0099	0.0117	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00985	0.0117	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00985	0.0117	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0109	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00894	0.0106	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00882	0.0105	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00853	0.0101	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00824	0.00977	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00792	0.00939	CcSEcCtD
Sodium lauryl sulfate—Rash—Hydrochlorothiazide—nephrolithiasis	0.00786	0.00931	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00785	0.0093	CcSEcCtD
Sodium lauryl sulfate—Headache—Hydrochlorothiazide—nephrolithiasis	0.00781	0.00925	CcSEcCtD
Sodium lauryl sulfate—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0074	0.00877	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00469	0.03	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00429	0.0274	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00429	0.0274	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00325	0.0208	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00325	0.0208	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00307	0.0196	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00302	0.0193	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00302	0.0193	CbGpPWpGaD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0027	0.0172	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00268	0.0171	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00268	0.0171	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00238	0.0152	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00218	0.0139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00218	0.0139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00165	0.0106	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00165	0.0106	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00158	0.0101	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—DGKH—nephrolithiasis	0.00158	0.0101	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00154	0.00982	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00154	0.00982	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00137	0.00876	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00137	0.00876	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0011	0.007	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GRHPR—nephrolithiasis	0.00095	0.00607	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AGXT—nephrolithiasis	0.000847	0.00541	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—APRT—nephrolithiasis	0.00072	0.0046	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC26A1—nephrolithiasis	0.00072	0.0046	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AQP1—nephrolithiasis	0.000513	0.00328	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CHRM3—nephrolithiasis	0.000464	0.00296	CbGpPWpGaD
